Bevacizumab in the Treatment of Ovarian Cancer

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s13071
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Critical Appraisal of Bevacizumab in the Treatment of Metastatic Colorectal Cancer

OncoTargets and Therapy
OncologyPharmacology
2012English

The Cost-Effectiveness of Bevacizumab in Advanced Ovarian Cancer Using Evidence From the ICON7 Trial

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

New Strategies in Ovarian Cancer: Translating the Molecular Complexity of Ovarian Cancer Into Treatment Advances

Clinical Cancer Research
Cancer ResearchOncology
2014English

Exciting Advancements in Ovarian Cancer Treatment

2019English

Treatment Decisions in Advanced Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

Modeling Efficacy of Bevacizumab Treatment for Metastatic Colon Cancer

Journal of Cancer
Oncology
2013English

Cardiovascular Toxicity of Bevacizumab in Long-Term Survival of Recurrent Ovarian Cancer: A Case Report

Cancer and Clinical Oncology
2016English

Profile of Olaparib in the Treatment of Advanced Ovarian Cancer

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy